The current status of T-cell depleted allogeneic stem-cell transplants in adult patients with AML.
Bunjes
D
D
Stem Cell Transplantation Programme, Department of Haematology/Oncology, Ulm University Hospital, FRG.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control; D000328:Adult; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000379:methods* / Q000639:trends; D015470:Leukemia, Myeloid, Acute / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D008232:Lymphoproliferative Disorders / Q000276:immunology / Q000503:physiopathology / Q000517:prevention & control; D012008:Recurrence; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods* / Q000639:trends; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D019172:Transplantation Conditioning / Q000009:adverse effects / Q000379:methods* / Q000639:trends; D014184:Transplantation, Homologous / Q000009:adverse effects / Q000379:methods* / Q000639:trends; D017211:Treatment Failure